Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Roles of Sall4 in the generation of pluripotent stem cells from blastocysts and fibroblasts.

Tsubooka N, Ichisaka T, Okita K, Takahashi K, Nakagawa M, Yamanaka S.

Genes Cells. 2009 Jun;14(6):683-94. doi: 10.1111/j.1365-2443.2009.01301.x.

2.

Induction of pluripotent stem cells from mouse fibroblasts by four transcription factors.

Yamanaka S.

Cell Prolif. 2008 Feb;41 Suppl 1:51-6. doi: 10.1111/j.1365-2184.2008.00493.x. Review.

PMID:
18181945
3.

The molecular mechanism of induced pluripotency: a two-stage switch.

Scheper W, Copray S.

Stem Cell Rev. 2009 Sep;5(3):204-23. doi: 10.1007/s12015-009-9077-x. Review.

PMID:
19551525
4.

Mouse induced pluripotent stem cells.

Geoghegan E, Byrnes L.

Int J Dev Biol. 2008;52(8):1015-22. doi: 10.1387/ijdb.082640eg. Review.

5.

Recent advances in cardiovascular regenerative medicine: the induced pluripotent stem cell era.

Yuasa S, Fukuda K.

Expert Rev Cardiovasc Ther. 2008 Jul;6(6):803-10. doi: 10.1586/14779072.6.6.803. Review.

PMID:
18570618
6.

[Induced pluripotent stem cells].

Shevchenko AI, Medvedev SP, Mazurok NA, Zakiian SM.

Genetika. 2009 Feb;45(2):160-8. Review. Russian.

PMID:
19334609
7.

Pluripotency maintenance mechanism of embryonic stem cells and reprogramming.

Masui S.

Int J Hematol. 2010 Apr;91(3):360-72. doi: 10.1007/s12185-010-0517-9. Review.

PMID:
20157790
8.

How is pluripotency determined and maintained?

Niwa H.

Development. 2007 Feb;134(4):635-46. Review.

9.

From fibroblasts to iPS cells: induced pluripotency by defined factors.

Zhao R, Daley GQ.

J Cell Biochem. 2008 Nov 1;105(4):949-55. doi: 10.1002/jcb.21871. Review.

PMID:
18668528
10.

Regulatory role of Klf5 in early mouse development and in embryonic stem cells.

Parisi S, Russo T.

Vitam Horm. 2011;87:381-97. doi: 10.1016/B978-0-12-386015-6.00037-8. Review.

PMID:
22127252
11.

Pluripotent stem cells and other technologies will eventually open the door for straightforward gene targeting in the rat.

Voigt B, Serikawa T.

Dis Model Mech. 2009 Jul-Aug;2(7-8):341-3. doi: 10.1242/dmm.002824. Review.

12.

[An overview of pluripotent stem cell lines].

Kieffer E, Kuntz S, Viville S.

Med Sci (Paris). 2010 Oct;26(10):848-54. doi: 10.1051/medsci/20102610848. Review. French.

13.

Molecular and biological properties of pluripotent embryonic stem cells.

Ohtsuka S, Dalton S.

Gene Ther. 2008 Jan;15(2):74-81. Review.

PMID:
17989701
14.

Determinants of pluripotency: from avian, rodents, to primates.

Martins-Taylor K, Xu RH.

J Cell Biochem. 2010 Jan 1;109(1):16-25. doi: 10.1002/jcb.22402. Review.

PMID:
19937733
15.

A transcriptional roadmap to the induction of pluripotency in somatic cells.

Wang Y, Mah N, Prigione A, Wolfrum K, Andrade-Navarro MA, Adjaye J.

Stem Cell Rev. 2010 Jun;6(2):282-96. doi: 10.1007/s12015-010-9137-2. Review.

PMID:
20336394
16.

Epigenetics in embryonic stem cells: regulation of pluripotency and differentiation.

Atkinson S, Armstrong L.

Cell Tissue Res. 2008 Jan;331(1):23-9. Review.

PMID:
18004593
17.

Expression and activation of the reprogramming transcription factors.

Guo J, Li ZC, Feng YH.

Biochem Biophys Res Commun. 2009 Dec 25;390(4):1081-6. doi: 10.1016/j.bbrc.2009.11.017. Review.

PMID:
19900408
18.

From skin to the treatment of diseases--the possibilities of iPS cell research in dermatology.

Galach M, Utikal J.

Exp Dermatol. 2011 Jun;20(6):523-8. doi: 10.1111/j.1600-0625.2011.01282.x. Review.

PMID:
21585557
19.

Understanding pluripotency--how embryonic stem cells keep their options open.

Johnson BV, Shindo N, Rathjen PD, Rathjen J, Keough RA.

Mol Hum Reprod. 2008 Sep;14(9):513-20. doi: 10.1093/molehr/gan048. Review.

20.

[Establishment of human embryonic stem cell lines and their therapeutic application].

Suemori H.

Rinsho Byori. 2004 Mar;52(3):254-8. Review. Japanese.

PMID:
15137326
Items per page

Supplemental Content

Support Center